BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21988306)

  • 21. Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report.
    Menéndez C; Moorthy VS; Reed Z; Bardají A; Alonso P; Brown GV
    Expert Rev Vaccines; 2011 Sep; 10(9):1271-80. PubMed ID: 21919617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of Plasmodium falciparum variant surface antigens in protective immunity and vaccine development.
    Hviid L
    Hum Vaccin; 2010 Jan; 6(1):84-9. PubMed ID: 19823032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin.
    Nielsen MA; Resende M; Alifrangis M; Turner L; Hviid L; Theander TG; Salanti A
    Exp Parasitol; 2007 Sep; 117(1):1-8. PubMed ID: 17442305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The case for a subunit vaccine against malaria.
    Anders RF
    Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy-associated malaria--on the brink?
    Craig AG
    Trends Parasitol; 2004 May; 20(5):201-4. PubMed ID: 15105015
    [No Abstract]   [Full Text] [Related]  

  • 26. Acquisition of antibodies to variant antigens on the surface of Plasmodium falciparum-infected erythrocytes during pregnancy.
    Fievet N; Le Hesran JY; Cottrell G; Doucoure S; Diouf I; Ndiaye JL; Bertin G; Gaye O; Sow S; Deloron P
    Infect Genet Evol; 2006 Nov; 6(6):459-63. PubMed ID: 16621725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective.
    Hviid L
    Parasite Immunol; 2004; 26(11-12):477-86. PubMed ID: 15771683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing vaccines to prevent malaria in pregnant women.
    Tuikue-Ndam N; Deloron P
    Expert Opin Biol Ther; 2015; 15(8):1173-82. PubMed ID: 26051589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional genomic technologies applied to the control of the human malaria parasite, Plasmodium falciparum.
    Carucci DJ
    Pharmacogenomics; 2001 May; 2(2):137-42. PubMed ID: 11368752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variant proteins on the surface of malaria-infected erythrocytes--developing vaccines.
    Duffy PE; Craig AG; Baruch DI
    Trends Parasitol; 2001 Aug; 17(8):354-6. PubMed ID: 11685888
    [No Abstract]   [Full Text] [Related]  

  • 31. Pregnancy-associated malaria and the prospects for syndrome-specific antimalaria vaccines.
    Smith JD; Deitsch KW
    J Exp Med; 2004 Nov; 200(9):1093-7. PubMed ID: 15520241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccines for malaria: the past, the present, & the future.
    Doolan DL; Hedstrom RC; Wang R; Sedegah M; Scheller LF; Hobart P; Norman JA; Hoffman SL
    Indian J Med Res; 1997 Aug; 106():109-19. PubMed ID: 9291681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field trials of malaria vaccines.
    Kitua AY
    Indian J Med Res; 1997 Aug; 106():95-108. PubMed ID: 9291680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-clinical and clinical development of the first placental malaria vaccine.
    Pehrson C; Salanti A; Theander TG; Nielsen MA
    Expert Rev Vaccines; 2017 Jun; 16(6):613-624. PubMed ID: 28434376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Plasmodium falciparum malaria vaccines: evidence-based searching for variant surface antigens as candidates for vaccination against pregnancy-associated malaria.
    Staalsoe T; Jensen AT; Theander TG; Hviid L
    Immunol Lett; 2002 Nov; 84(2):133-6. PubMed ID: 12270550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Women and malaria--special risks and appropriate control strategy.
    Reuben R
    Soc Sci Med; 1993 Aug; 37(4):473-80. PubMed ID: 8211259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing pregnancy malaria. Simple vaccines that stop parasites lodging in the placenta may save thousands of lives.
    McCarthy M
    Lancet; 2004 Jan; 363(9403):132-3. PubMed ID: 14733187
    [No Abstract]   [Full Text] [Related]  

  • 38. Malaria vaccine trials in pregnant women: An imperative without precedent.
    Healy SA; Fried M; Richie T; Bok K; Little M; August A; Riley L; Swamy GK; Wylie BJ; Menendez C; Muehlenbachs A; Doumbo O; Greenwood B; Billingsley PF; Hoffman SL; Duffy PE
    Vaccine; 2019 Feb; 37(6):763-770. PubMed ID: 30621913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal immunization and malaria in pregnancy.
    Duffy PE
    Vaccine; 2003 Jul; 21(24):3358-61. PubMed ID: 12850339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children.
    Trape JF; Rogier C
    Lancet; 1995 Jan; 345(8942):134-5. PubMed ID: 7815878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.